Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Purchased by Bank of New York Mellon Corp

Bank of New York Mellon Corp grew its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 2.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 49,604 shares of the medical instruments supplier’s stock after acquiring an additional 1,391 shares during the quarter. Bank of New York Mellon Corp owned about 1.41% of Utah Medical Products worth $3,314,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the company. Quadrature Capital Ltd boosted its stake in Utah Medical Products by 177.6% during the 1st quarter. Quadrature Capital Ltd now owns 32,310 shares of the medical instruments supplier’s stock valued at $2,294,000 after purchasing an additional 20,671 shares during the period. Penn Mutual Asset Management LLC grew its holdings in Utah Medical Products by 46.3% in the 4th quarter. Penn Mutual Asset Management LLC now owns 53,093 shares of the medical instruments supplier’s stock worth $4,471,000 after buying an additional 16,810 shares in the last quarter. Isthmus Partners LLC increased its position in Utah Medical Products by 56.8% in the 1st quarter. Isthmus Partners LLC now owns 35,602 shares of the medical instruments supplier’s stock valued at $2,532,000 after acquiring an additional 12,903 shares during the period. Vanguard Group Inc. raised its stake in Utah Medical Products by 7.3% during the 1st quarter. Vanguard Group Inc. now owns 183,141 shares of the medical instruments supplier’s stock valued at $13,023,000 after acquiring an additional 12,402 shares in the last quarter. Finally, Los Angeles Capital Management LLC boosted its position in Utah Medical Products by 127.0% during the 1st quarter. Los Angeles Capital Management LLC now owns 13,086 shares of the medical instruments supplier’s stock worth $931,000 after acquiring an additional 7,320 shares during the period. Institutional investors own 69.60% of the company’s stock.

Utah Medical Products Stock Performance

Shares of UTMD opened at $68.03 on Friday. Utah Medical Products, Inc. has a one year low of $65.60 and a one year high of $89.15. The stock’s fifty day moving average is $68.23 and its 200-day moving average is $68.31. The firm has a market capitalization of $236.74 million, a price-to-earnings ratio of 15.12 and a beta of 0.08.

Utah Medical Products (NASDAQ:UTMD) last released its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.98 EPS for the quarter. The firm had revenue of $10.40 million for the quarter. Utah Medical Products had a net margin of 33.56% and a return on equity of 12.41%.

Utah Medical Products Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 4th. Investors of record on Friday, September 20th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, September 20th. This represents a $1.20 annualized dividend and a yield of 1.76%. Utah Medical Products’s payout ratio is 26.67%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.